Top Markets
#1 COTI COTI +38.86%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +32.35%
#3 Fabric Protocol Fabric Protocol +30.24%
#4 GALA GALA +30.05%
#5 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +29.48%
#6 Bitcoin Cash Bitcoin Cash +29.01%
#7 Tutorial Tutorial +28.70%
#8 Talus Network Talus Network +25.87%
#9 Zora Zora +24.18%
#10 Magma Finance Magma Finance +24.04%
Coin of the day
COTI COTI
Settings
Language
ENGLISH
Currency
USD
Theme
Achilles Therapeutics plc Achilles Therapeutics plc

Achilles Therapeutics plc

ACHL
Rank in Stocks #24575
Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused... Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused on immuno-oncology. The firm specializes in creating innovative precision T-cell therapies designed to combat a range of solid tumors. Its primary therapeutic candidates, both currently undergoing Phase I/IIa clinical trials, are CHIRON, aimed at advanced non-small cell lung cancer, and THETIS, targeting metastatic or recurrent melanoma. Beyond these, Achilles is also advancing its pipeline with treatments for head and neck squamous cell carcinoma, renal cell carcinoma, triple-negative breast cancer, and bladder cancer. Initially incorporated as Achilles TX Limited, the company officially adopted the name Achilles Therapeutics Plc in February 2021. Established in 2016, its corporate headquarters are situated in London, United Kingdom.
Share Price
$1.48
Last synced: 2025-03-24
Market Cap
$59.05M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
GB
Trade Achilles Therapeutics plc (ACHL)

Category

Healthcare
Stock price history for Achilles Therapeutics plc (ACHL)
Highest end of day price: $1.42 on 2025-03-01

Lowest end of day price: $16.55 on 2021-03-01
Stock price history of Achilles Therapeutics plc from 2021 to 2026
Annual Stock Price Performance
Year Performance
2025 35.96%
2024 21.05%
2023 -23.13%
2022 -77.06%
2021 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.26 37.69%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 57.37%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.66 455.53%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -18.24%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 9.84%
CH